ClearPoint Neuro, Inc. Common Stock (CLPT)
ClearPoint Neuro, Inc. (CLPT) specializes in neurodiagnostic and neurosurgical technologies, focusing on delivering precision-guided solutions for minimally invasive brain treatments. The company's systems are used for procedures such as deep brain stimulation, biopsies, and drug delivery, aiming to improve patient outcomes through advanced neuro-navigation and imaging techniques.
Company News
The global MRI-guided neurosurgical ablation market is expected to grow significantly, reaching a value of USD 227.56 million by 2034, driven by advancements in technology, regulatory approvals, and enhanced healthcare accessibility.
ClearPoint (CLPT) announces the full market release of the SmartFrame OR platform, intended for performing DBS, and Prism Neuro Laser Therapy System for providing thermal therapy.
Upgrades For Martin Marietta Materials Inc (NYSE:MLM), Seaport Global upgraded the previous rating of Neutral to Buy. For the second quarter, Martin Marietta Materials had an EPS of $5.60, compared to year-ago quarter EPS of $3.96. The current stock performance of Martin Marietta Materials shows a 52-week-high of $463.41 and a 52-week-low of $304...
CLPT earnings call for the period ending June 30, 2022.